Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Sponsor content
352 result(s) found, displaying 261 to 270
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Pembrolizumab [Keytruda]
-
Prescription medicine registrationActive ingredients: letermovir.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationPriority review
-
Designation or determinationProvisional approval
-
Prescription medicine registrationActive ingredients: ertugliflozin.
-
Prescription medicine registrationActive ingredients: ertugliflozin and sitagliptin phosphate monohydrate.